6879.TWO TCI GENE Inc.

Healthcare Biotechnology Taiwan OTC Exchange
34.65 TWD
Close of Nov 6, 2026
32.35 41.05
Market cap
TWD 917M
P/E
18.2x
P/B
1.10x
ROE
4.6%
Dividend yield
5.77%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6879.TWO undervalued?

Graham number
Price34.65
Graham value36.71
Discount5.6%

6879.TWO trades 5.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

TCI GENE Inc. fundamental analysis

No fundamental analysis for TCI GENE Inc. yet.

TCI GENE Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About TCI GENE Inc.

TCI GENE Inc., together with its subsidiaries, provides genetic testing and assessment services in Taiwan and Mainland China. It operates through Inspection and Consumable Products segments. The company offers memory, anti-aging, health management, child growth and development, nutritional metabolism and absorption, OB weight management, and SC skin management genetic testing; gut microbiota testing; and LDT cardiovascular drug gene testing services. It also provides precisi…

Full company profile